Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Medicine|November 3, 2017
Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case reportFu-Biao Kang, Ling Wang, Dian-Xing Sun
International Journal of Cancer|September 10, 2013
B7-H3-mediated tumor immunology: Friend or foe?Ling Wang, Fu-Biao Kang, Bao-En Shan
Pharmacological Research|March 1, 2020
The diverse functions of Siglec-15 in bone remodeling and antitumor responsesFu-Biao Kang, Wei Chen, Ling Wang, et al.
Biomarker Research|April 14, 2022
The intriguing roles of Siglec family members in the tumor microenvironmentKui-Ying Jiang, Li-Li Qi, Fu-Biao Kang, et al.
Anti-Cancer Drugs|October 19, 2018
Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathwayLing Wang, Fu-Biao Kang, Juan Wang, et al.
Cancer Cell International|July 17, 2018
B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancerLing Wang, Chao Yang, Xin-Bo Liu, et al.
Oncology Reports|November 6, 2014
Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expressionFu-Biao Kang, Ling Wang, Dong Li, et al.
Biomed Research International|January 18, 2020
hsa_circ0021347 as a Potential Target Regulated by B7-H3 in Modulating the Malignant Characteristics of OsteosarcomaLing Wang, Guo-Chuan Zhang, Fu-Biao Kang, et al.
Cancer Cell International|August 21, 2018
Clinical significance of serum soluble B7-H3 in patients with osteosarcomaLing Wang, Fu-Biao Kang, Guo-Chuan Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 21, 2016
The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcomaLing Wang, Fu-Biao Kang, Nan Sun, et al.
Pageof 2